Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term LMWH vs VKA for VTE in Cancer Patients
NCT01164046Phase 3Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2010
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by University Medical Center Groningen. Started Aug 2010; status: terminated.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01164046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01164046.